Covered recipient · General Payments record
AMY RENEA EVANS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,146.90
- Reported across 157 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $736.37 | 54 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $223.31 | 22 |
| Novo Nordisk AS | $158.66 | 13 |
| Lilly USA, LLC | $133.39 | 12 |
| Inspire Medical Systems, Inc. | $111.65 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.40 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.71 | 1 |
| IBSA Pharma Inc. | $17.43 | 1 |
| GlaxoSmithKline, LLC. | $16.70 | 1 |
| Exact Sciences Corporation | $16.66 | 1 |
| Currax Pharmaceuticals LLC | $14.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.73 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082548 | CMS |
| ABBVIE INC. | $8.57 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082550 | CMS |
| ABBVIE INC. | $21.19 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082552 | CMS |
| ABBVIE INC. | $12.53 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082554 | CMS |
| ABBVIE INC. | $7.57 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082556 | CMS |
| ABBVIE INC. | $9.29 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082558 | CMS |
| ABBVIE INC. | $6.42 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082560 | CMS |
| ABBVIE INC. | $6.33 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082562 | CMS |
| ABBVIE INC. | $8.02 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082564 | CMS |
| ABBVIE INC. | $19.40 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082566 | CMS |
| ABBVIE INC. | $20.14 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082568 | CMS |
| ABBVIE INC. | $18.61 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082570 | CMS |
| ABBVIE INC. | $5.22 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082572 | CMS |
| ABBVIE INC. | $6.86 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082574 | CMS |
| ABBVIE INC. | $5.48 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082576 | CMS |
| ABBVIE INC. | $7.57 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082578 | CMS |
| ABBVIE INC. | $6.71 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082580 | CMS |
| ABBVIE INC. | $12.84 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082582 | CMS |
| ABBVIE INC. | $17.48 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082584 | CMS |
| ABBVIE INC. | $2.69 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082586 | CMS |
| ABBVIE INC. | $6.37 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082588 | CMS |
| ABBVIE INC. | $6.29 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107082590 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.71 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117859211 | CMS |
| Currax Pharmaceuticals LLC | $14.46 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089517730 | CMS |
| Exact Sciences Corporation | $16.66 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114545247 | CMS |
| GlaxoSmithKline, LLC. | $16.70 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115893975 | CMS |
| IBSA Pharma Inc. | $17.43 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142973151 | CMS |
| Inspire Medical Systems, Inc. | $111.65 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148147656 | CMS |
| Lilly USA, LLC | $16.19 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135446587 | CMS |
| Lilly USA, LLC | $13.80 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135530269 | CMS |
| Lilly USA, LLC | $8.18 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135524883 | CMS |
| Lilly USA, LLC | $16.53 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135446589 | CMS |
| Lilly USA, LLC | $2.49 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135505946 | CMS |
| Lilly USA, LLC | $16.63 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135521077 | CMS |
| Lilly USA, LLC | $9.56 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135508770 | CMS |
| Lilly USA, LLC | $14.55 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135446591 | CMS |
| Lilly USA, LLC | $2.56 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135530273 | CMS |
| Lilly USA, LLC | $10.51 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135521079 | CMS |
| Lilly USA, LLC | $13.18 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135530277 | CMS |
| Lilly USA, LLC | $9.21 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135467054 | CMS |
| Novo Nordisk Inc | $7.52 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100437083 | CMS |
| Novo Nordisk Inc | $14.39 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100261117 | CMS |
| Novo Nordisk Inc | $6.61 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100382411 | CMS |
| Novo Nordisk Inc | $13.21 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100378577 | CMS |
| Novo Nordisk Inc | $6.48 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100573050 | CMS |
| Novo Nordisk Inc | $17.15 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100286274 | CMS |
| Novo Nordisk Inc | $28.81 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100557553 | CMS |
| Novo Nordisk Inc | $7.84 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100588789 | CMS |
| Novo Nordisk Inc | $15.72 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100418764 | CMS |
| Novo Nordisk Inc | $9.23 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100372042 | CMS |
| Novo Nordisk Inc | $7.47 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100591420 | CMS |
| Novo Nordisk Inc | $17.69 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100392902 | CMS |
| Novo Nordisk Inc | $6.54 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100306163 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.40 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137740466 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.